Kvantify

Kvantify is a Danish deep-tech company developing advanced computational software designed to accelerate early-stage drug discovery. By combining high-performance computing with emerging quantum computing capabilities, the company enables pharmaceutical and biotech researchers to simulate how molecules interact with biological targets before conducting laboratory experiments.

Drug discovery is traditionally a slow, expensive, and uncertain process. In the early stages of research, thousands of potential compounds must be tested to identify a small number of promising candidates. Kvantify addresses this challenge through its proprietary software platform, which performs physics-based simulations that can predict molecular binding behaviour with high accuracy. This allows researchers to prioritize the most promising drug candidates digitally, reducing the number of costly and time-consuming lab experiments.

The company’s platform technology is built to operate at the intersection of classical high-performance computing and future quantum computing infrastructure. As quantum hardware matures, Kvantify’s algorithms and software architecture are designed to integrate with these systems, enabling even more advanced molecular simulations and expanding the possibilities for computational drug discovery.

Kvantify operates at the intersection of physics, computer science, chemistry, and life science. The company collaborates with pharmaceutical and biotech organisations to integrate computational modelling into their research workflows, helping to accelerate the development of new medicines while lowering the cost of early-stage R&D.

The company was founded by researchers from Aarhus University and has built a highly interdisciplinary team with expertise spanning quantum computing, algorithm development, artificial intelligence, quantum chemistry, mathematics, and bioinformatics. This combination of scientific depth and software engineering capability enables Kvantify to develop computational tools addressing some of the most complex challenges in molecular discovery.

Kvantify is currently focused on scaling the commercial adoption of its software platform and expanding collaborations with international life science partners.

Key facts

• Danish deep-tech company founded in 2022
• Develops computational software for accelerating drug discovery
• Combines high-performance computing and quantum-ready algorithms
• Proprietary platform enabling faster and more precise molecular simulations
• Addresses a growing global market for computational drug discovery tools
• Collaborates with pharma and biotech organisations
• Spinout rooted in the research environment at Aarhus University

Team

• Jörg Weiser, Executive Chairperson & Interim CEO
• Nikolaj Zinner, Co-founder & CSO
• Allan Grønlund, Co-founder & CTO
• Christina Krogsgård Nielsen, COO
• Tobias Jerichow, CFO
• Casper Kirkegaard, Head of Engineering